This work represents the first evidence of the influence of COX-2 on NK cell function as a crucial element in the efficacy of anti-CTLA-4 therapy for ovarian cancer patients that exhibited high tumoral levels of CTLA-4. The gene discussed is CTLA4; the disease is ovarian carcinoma.